VIXAREZ Trademark

Trademark Overview

On Tuesday, September 28, 2021, a trademark application was filed for VIXAREZ with the United States Patent and Trademark Office. The USPTO has given the VIXAREZ trademark a serial number of 97048652. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, June 3, 2025. This trademark is owned by ACORDA THERAPEUTICS, INC.. The VIXAREZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, pharmaceutical and biological preparations used in the treatment of diseases, disorders or conditions of the nervous system; all excluding pharmaceuticals for the treatment or management of cancer and cancer related symptoms
vixarez

General Information

Serial Number97048652
Word MarkVIXAREZ
Filing DateTuesday, September 28, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, June 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical products, namely, pharmaceutical and biological preparations used in the treatment of diseases, disorders or conditions of the nervous system; all excluding pharmaceuticals for the treatment or management of cancer and cancer related symptoms

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 27, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameACORDA THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPearl River, NY 10965

Trademark Events

Event DateEvent Description
Friday, October 1, 2021NEW APPLICATION ENTERED
Wednesday, October 27, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 2, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 2, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 2, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 2, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 2, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 28, 2022ASSIGNED TO EXAMINER
Tuesday, June 28, 2022NON-FINAL ACTION WRITTEN
Tuesday, June 28, 2022NON-FINAL ACTION E-MAILED
Tuesday, June 28, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 28, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 28, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 26, 2023SUSPENSION LETTER WRITTEN
Thursday, January 26, 2023LETTER OF SUSPENSION E-MAILED
Thursday, January 26, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, April 1, 2023LETTER OF PROTEST EVIDENCE FORWARDED
Tuesday, May 23, 2023LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Thursday, August 10, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, October 5, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, October 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 29, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, November 9, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, May 10, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, February 24, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 3, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, June 3, 2025ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, February 24, 2025NON-FINAL ACTION E-MAILED
Monday, February 24, 2025NON-FINAL ACTION WRITTEN

Related Keywords

vixarez cancer treatment pharmaceutical excluding system management symptoms related nervous pharmaceuticals